Pharma & Biotech

The investment community is closely monitoring Incyte Corporation as a significant regulatory milestone approaches. A forthcoming decision by the U.S....

Sarepta Therapeutics shares closed Friday's trading session down 2.9 percent at $17.39, a decline that occurred despite a positive earnings...

BioNTech SE finds its equity caught in a significant downdraft, pressured not by its fundamentals but by emerging political risks...

Investors in Xeris Biopharma Holdings, Inc. are currently weighing contradictory market signals that present a compelling investment puzzle. On one...

Investor sentiment surrounding Ocular Therapeutix is currently a study in contrasts. The biopharmaceutical company finds itself at a crossroads, buoyed...

Eli Lilly confronts significant challenges this week as a US appellate court upheld a substantial $184 million penalty against the...

A bombshell report from the Washington Post triggered a dramatic selloff in BioNTech shares this week, wiping out gains from...

Viking Therapeutics finds itself navigating turbulent waters as its stock experiences a pronounced downward trajectory. Investor confidence has been significantly...

Protagonist Therapeutics Inc. saw its shares close at $58.86 on Friday, registering a decline of 1.37%, despite a significant corporate...

A substantial institutional investor has significantly reduced its stake in Veeva Systems, the specialized life sciences software provider. Despite the...